ES2082023T3 - Soluciones inyectables listas para su utilizacion que contienen un agente antitumoral del tipo antraciclina glucosido. - Google Patents

Soluciones inyectables listas para su utilizacion que contienen un agente antitumoral del tipo antraciclina glucosido.

Info

Publication number
ES2082023T3
ES2082023T3 ES91102986T ES91102986T ES2082023T3 ES 2082023 T3 ES2082023 T3 ES 2082023T3 ES 91102986 T ES91102986 T ES 91102986T ES 91102986 T ES91102986 T ES 91102986T ES 2082023 T3 ES2082023 T3 ES 2082023T3
Authority
ES
Spain
Prior art keywords
anthracicline
injectable solutions
use containing
solutions ready
tumoral agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91102986T
Other languages
English (en)
Inventor
Gaetano Gatti
Diego Oldani
Giuseppe Bottoni
Carlo Confalonieri
Luciano Gambini
Ponti Roberto De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Pharmacia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26291656&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2082023(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB868629193A external-priority patent/GB8629193D0/en
Application filed by Pharmacia SpA filed Critical Pharmacia SpA
Application granted granted Critical
Publication of ES2082023T3 publication Critical patent/ES2082023T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

UNA SOLUCION INYECTABLE DE GLUCOSIDO DE ANTRACICLINA, DE CONSERVACION ESTABLE, ESTERIL, LIBRE DE PIROGENOS, QUE CONSTA ESENCIALMENTE DE UNA SAL FISIOLOGICAMENTE ACEPTABLE Y DE UN GLUCOSIDO DE ANTRACICLINA MEZCLADO CON UN DISOLVENTE, TAMBIEN FISIOLOGICAMENTE ACEPTABLE, DE LA MISMA SUSTANCIA, QUE NO HA SIDO RECONSTITUIDO DE UN LIOFILIZADO Y CUYO PH HA SIDO AJUSTADO DE 2.5 A 4.0.
ES91102986T 1986-12-05 1987-12-03 Soluciones inyectables listas para su utilizacion que contienen un agente antitumoral del tipo antraciclina glucosido. Expired - Lifetime ES2082023T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868629193A GB8629193D0 (en) 1986-12-05 1986-12-05 Injectable ready-to-use solutions
US6465387A 1987-06-22 1987-06-22

Publications (1)

Publication Number Publication Date
ES2082023T3 true ES2082023T3 (es) 1996-03-16

Family

ID=26291656

Family Applications (3)

Application Number Title Priority Date Filing Date
ES95101919T Expired - Lifetime ES2198424T3 (es) 1986-12-05 1987-12-03 Soluciones inyectables listas para el empleo que contienen doxorrubicina.
ES198787310632T Expired - Lifetime ES2039460T3 (es) 1986-12-05 1987-12-03 Un procedimiento para producir una solucion inyectable de glicosido de antraciclina.
ES91102986T Expired - Lifetime ES2082023T3 (es) 1986-12-05 1987-12-03 Soluciones inyectables listas para su utilizacion que contienen un agente antitumoral del tipo antraciclina glucosido.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES95101919T Expired - Lifetime ES2198424T3 (es) 1986-12-05 1987-12-03 Soluciones inyectables listas para el empleo que contienen doxorrubicina.
ES198787310632T Expired - Lifetime ES2039460T3 (es) 1986-12-05 1987-12-03 Un procedimiento para producir una solucion inyectable de glicosido de antraciclina.

Country Status (22)

Country Link
EP (4) EP1283044A3 (es)
JP (1) JP2621255B2 (es)
KR (2) KR0158672B1 (es)
CN (1) CN1058391C (es)
AT (2) ATE129896T1 (es)
AU (1) AU632036B2 (es)
BE (1) BE1000540A5 (es)
CH (1) CH680494A5 (es)
DE (4) DE3777365D1 (es)
DK (1) DK175815B1 (es)
ES (3) ES2198424T3 (es)
FI (1) FI91710C (es)
FR (1) FR2607702B1 (es)
GB (1) GB2200047B (es)
GR (2) GR871846B (es)
HK (2) HK39591A (es)
IT (1) IT1226072B (es)
NL (1) NL8702914A (es)
NO (1) NO175802C (es)
PT (1) PT86285B (es)
SE (1) SE512881C2 (es)
SG (1) SG36591G (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8519452D0 (en) * 1985-08-02 1985-09-11 Erba Farmitalia Injectable solutions
DE10300323A1 (de) * 2003-01-09 2004-10-14 Baxter Healthcare S.A. Sicherheitsbehälter mit erhöhter Bruch und Splitterfestigkeit sowie kontaminationsfreier Außenfläche für biologisch aktive Substanzen und Verfahren zu deren Herstellung
CN1525856A (zh) * 2001-05-11 2004-09-01 三菱制药株式会社 含吡唑啉酮衍生物的稳定的高浓度注射剂
WO2006085336A2 (en) * 2005-02-11 2006-08-17 Dabur Pharma Limited Stabilized anthracycline glycoside pharmaceutical compositions
KR20070088447A (ko) * 2005-05-11 2007-08-29 시코르, 인크. 안정한 동결건조된 안트라사이클린 글리코시드
JP4456177B2 (ja) * 2007-09-04 2010-04-28 明治製菓株式会社 注射剤、注射液および注射用キット製剤
EP2174651A1 (en) * 2008-10-09 2010-04-14 Charité-Universitätsmedizin Berlin (Charité) A polymer-free hydrogel
CN102614118B (zh) * 2012-03-15 2014-04-30 北京协和药厂 注射用盐酸表柔比星制剂的制备方法及制剂
CN111617030B (zh) * 2020-05-22 2021-09-07 广东药科大学 壳寡糖口服液及其在制备减肥药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177264A (en) * 1977-10-17 1979-12-04 Sri International N-benzyl anthracyclines
GB2007645B (en) * 1977-10-17 1982-05-12 Stanford Res Inst Int Benzyl anthracyclines and pharmaceutical compositions containing them
GB2187311B (en) * 1984-07-27 1988-02-10 Ae Plc Automatic vehicle speed control system
GB8426672D0 (en) * 1984-10-22 1984-11-28 Erba Farmitalia Pharmaceutical compositions
GB8519452D0 (en) * 1985-08-02 1985-09-11 Erba Farmitalia Injectable solutions
JPH0655667A (ja) * 1992-08-06 1994-03-01 Nippon Zeon Co Ltd 複合成形体

Also Published As

Publication number Publication date
DK635287A (da) 1988-06-06
KR0158672B1 (en) 1998-12-01
HK39591A (en) 1991-05-31
NO175802C (no) 1994-12-14
DE3741037A1 (de) 1988-06-09
DE3752368T2 (de) 2004-02-12
AU8205987A (en) 1988-06-09
DE3751589T2 (de) 1996-05-02
EP0273603A2 (en) 1988-07-06
IT8722869A0 (it) 1987-12-03
GB2200047A (en) 1988-07-27
EP0659435A1 (en) 1995-06-28
NO875055L (no) 1988-06-06
EP1283044A3 (en) 2003-05-14
SE8704849D0 (sv) 1987-12-03
EP0438183A1 (en) 1991-07-24
NO175802B (no) 1994-09-05
EP0273603B1 (en) 1992-03-11
EP0659435B1 (en) 2003-05-14
SE512881C2 (sv) 2000-05-29
FR2607702A1 (fr) 1988-06-10
GR871846B (en) 1988-04-01
DK175815B1 (da) 2005-03-07
AU632036B2 (en) 1992-12-17
FI91710C (fi) 1994-08-10
GR3004303T3 (es) 1993-03-31
ES2198424T3 (es) 2004-02-01
EP0438183B1 (en) 1995-11-08
DE3752368D1 (de) 2003-06-18
ATE240108T1 (de) 2003-05-15
ATE129896T1 (de) 1995-11-15
KR960007861B1 (ko) 1996-06-13
CN1058391C (zh) 2000-11-15
ES2039460T3 (es) 1993-10-01
FI91710B (fi) 1994-04-29
GB8728313D0 (en) 1988-01-06
DE3751589D1 (de) 1995-12-14
DE3777365D1 (de) 1992-04-16
SE8704849L (sv) 1988-06-06
FR2607702B1 (fr) 1991-08-16
DK635287D0 (da) 1987-12-03
JPS63215633A (ja) 1988-09-08
NO875055D0 (no) 1987-12-03
NL8702914A (nl) 1988-07-01
HK1011288A1 (en) 1999-07-09
EP1283044A2 (en) 2003-02-12
HK1049440A1 (en) 2003-05-16
IT1226072B (it) 1990-12-10
SG36591G (en) 1991-06-21
CN87108225A (zh) 1988-09-14
BE1000540A5 (fr) 1989-01-24
FI875340A0 (fi) 1987-12-03
KR880007086A (ko) 1988-08-26
PT86285B (pt) 1990-11-07
PT86285A (en) 1988-01-01
CH680494A5 (es) 1992-09-15
FI875340L (fi) 1988-06-06
GB2200047B (en) 1990-11-21
JP2621255B2 (ja) 1997-06-18
EP0273603A3 (en) 1988-07-20

Similar Documents

Publication Publication Date Title
ES2040232T3 (es) Preparaciones medicinales para administracion oral conteniendo una sola dosis de 10 a 240 mg de dihidropiridina.
ES2010226A6 (es) Un procedimiento para producir una preparacion farmaceutica estable que contiene un factor estimulante de colonias de granulocitos
ES2044829T1 (es) Una composicion para el tratamiento in vivo de da\os en los tejidos producidos por isquemia u otra disfuncion proveniente de oxidacion.
ES2044952T3 (es) Composiciones estabilizadas que contienen factor de crecimiento epidermico.
ES2046225T3 (es) Preparaciones regenerantes del cabello.
LU90283I2 (fr) Sporanox soluté buvable et ses dérivés pharmaceutiquement acceptables
ES2093735T3 (es) Derivados de melatonina para uso en la terapia de trastornos del sueño y en medicacion preanestesica.
LU90192I2 (fr) Desirudine et ses sels et dérivés pharmaceutiquement acceptables (revasc)
SE8402551D0 (sv) Cinnamoylmoranolin-derivat
IT1200589B (it) Derivati naturali attivita farmagologica
ATE157251T1 (de) Verwendung von inositoltriphosphat zur behandlung von entzündungen
ES2037086T3 (es) Procedimiento para preparar formulaciones farmaceuticas.
AR247984A1 (es) Metodo para la preparacion de una composicion sinergica que tiene actividad antiplaca o antigingivitis
ES2082023T3 (es) Soluciones inyectables listas para su utilizacion que contienen un agente antitumoral del tipo antraciclina glucosido.
MX9205568A (es) Composicion farmaceutica que contiene cantidades de 5-amino-1beta-d-ribofuranosil-imidazol-4-carboxamida.
RU93058532A (ru) Фармацевтическая композиция для остеоиндукции, способ генерации новой кости
DE3773893D1 (de) Synergistische kombination von azelastin und theophyllin oder azelastin und beta-mimetika.
MY103079A (en) New ophtalmological composition of matter
NO891220D0 (no) Middel som inneholder salicylsyre for behandling av lepidose.
ATE8739T1 (de) Pharmazeutische zubereitungen.
MC1930A1 (fr) Produit antiviral
ES2052670T3 (es) Utilizacion de derivados de 2-pirimidinil-1-piperazina.
ES548988A0 (es) Procedimiento de solubilizacion,en el momento del empleo,de un principio activo lipofilo en una solucion acuosa,con ob- jeto de su administracion por via intravenosa
ES2103811T3 (es) Terapia antiviral.
ES469908A1 (es) Procedimiento de utilizacion de salinomicina.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 438183

Country of ref document: ES